sezolamide has been researched along with Ocular Hypertension in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 15 (88.24) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brechue, WF; Maren, TH | 1 |
Bosc, JM; Bron, AM; George, JL; Greve, EL; Gunning, FP; Lesure, P; Royer, JG; Sirbat, D | 1 |
Béchetoille, A; Brunner-Ferber, FL; Buntinx, A; Clineschmidt, C; Gerling, J; Grehn, F; Gunning, F; Holder, D; Lippa, EA; Pfeiffer, N | 1 |
Camras, CB; Deasy, D; Framm, L; Lippa, EA; Lustgarten, J; Payne, JE; Podos, SM; Serle, JB | 1 |
Béchetoille, A; Gerling, J; Grehn, F; Greve, E; Gunning, F; Jaquet-Müller, F; Lippa, EA; Pfeiffer, N | 1 |
Aasved, H; Airaksinen, PJ; Alm, A; Bertelsen, T; Calissendorff, B; Dithmer, O; Eriksson, LO; Gustad, L; Høvding, G; Lippa, EA | 1 |
Bénichou, C; Bron, A; Clineschmidt, C; Flament, J; Gunning, F; Lesure, P; Lippa, EA; Panebianco, D; Royer, J; Sirbat, D | 1 |
Deasy, DA; Epstein, DL; Higginbotham, EJ; Holder, DJ; Kass, MA; Lippa, EA; Schuman, JS; Shaw, B; Skuta, GL; Weinreb, RN | 1 |
Baldwin, JJ; Mallorga, P; Ponticello, GS; Schwam, H; Sugrue, MF | 1 |
Camras, CB; Lippa, EA; Lustgarten, JS; Panebianco, DL; Podos, SM; Serle, JB | 1 |
Garus, H; Grehn, F; Hennekes, R; Pfeiffer, N | 1 |
Brunner-Ferber, FL; Garus, H; Grehn, F; Hennekes, R; Lippa, EA; Pfeiffer, N | 1 |
Bechetoille, A; Brunner-Ferber, F; Diestelhorst, M; Krieglstein, GK; Lippa, E | 1 |
Baldwin, JJ; Christy, ME; Gautheron, P; Grove, J; Mallorga, P; Ponticello, GS; Schwam, H; Sugrue, MF; Viader, MP | 1 |
Batenhorst, RL; Higginbotham, EJ; Kass, MA; Lippa, EA; Panebianco, DL; Wilensky, JT | 1 |
Bron, AM; Brunner-Ferber, FL; Feicht, BI; Hofmann, HM; Lippa, EA; Panebianco, DL; Royer, JG; Von Denffer, HA | 1 |
Kass, MA | 1 |
13 trial(s) available for sezolamide and Ocular Hypertension
Article | Year |
---|---|
Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Delivery Systems; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Polysaccharides, Bacterial; Sulfonamides; Thiophenes | 1993 |
Sezolamide: additivity to timolol twice daily.
Topics: Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol | 1992 |
Six week safety study of 2% MK-927 administered twice daily to ocular hypertensive volunteers.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Administration Schedule; Humans; Intraocular Pressure; Middle Aged; Ocular Hypertension; Safety; Sulfonamides; Thiophenes; Timolol | 1992 |
[Additive effect of timolol and the local carbonic anhydrase inhibitor MK-417 (sezolamide)].
Topics: Aged; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol | 1991 |
Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Placebos; Sulfonamides; Thiophenes | 1991 |
Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Stereoisomerism; Sulfonamides; Thiophenes | 1991 |
MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes | 1991 |
MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility.
Topics: Administration, Topical; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Time Factors | 1990 |
[Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
Topics: Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes | 1990 |
A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
Topics: Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes | 1990 |
[Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].
Topics: Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Racemases and Epimerases; Sulfonamides; Thiophenes | 1990 |
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Time Factors; Visual Acuity | 1990 |
MK-927: a topically effective carbonic anhydrase inhibitor in patients.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Placebos; Random Allocation; Sulfonamides; Thiophenes | 1989 |
4 other study(ies) available for sezolamide and Ocular Hypertension
Article | Year |
---|---|
pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
Topics: Animals; Carbonic Anhydrase Inhibitors; Eye; Hydrogen-Ion Concentration; Imidazoles; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Osmolar Concentration; Rabbits; Solubility; Sulfonamides; Thiophenes | 1993 |
A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Chymotrypsin; Ciliary Body; Erythrocytes; Female; In Vitro Techniques; Iris; Light Coagulation; Macaca fascicularis; Male; Ocular Hypertension; Ocular Hypotension; Rabbits; Sulfonamides; Thiophenes; Trabeculectomy | 1990 |
MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Chymotrypsin; Ciliary Body; Dose-Response Relationship, Drug; Female; Intraocular Pressure; Iris; Kinetics; Macaca fascicularis; Male; Ocular Hypertension; Rabbits; Sulfonamides; Thiophenes | 1990 |
Topical carbonic anhydrase inhibitors.
Topics: Administration, Topical; Benzothiazoles; Carbonic Anhydrase Inhibitors; Ethoxzolamide; Gels; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Sulfonamides; Thiazoles; Thiophenes | 1989 |